We are live on
!
Find out more
ACM
Accipiter Capital Management Portfolio holdings
AUM
$124M
1-Year Est. Return
6.47%
This Fund
S&P 500
This Quarter
Est. Return
-14.7%
1 Year Est. Return
-6.47%
3 Year Est. Return
-55.92%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$47.4M
AUM Growth
-$1.82M
(-3.7%)
Cap. Flow
+$5.66M
Cap. Flow
% of AUM
11.95%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
2
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$6.8M |
| 2 |
SHPG
Shire pic
SHPG
|
+$4.13M |
| 3 |
FELP
Foresight Energy LP
FELP
|
+$124K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$5.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 56.96% |
| 2 | Healthcare | 43.04% |
Similar funds
ACM
MCM
TCM
ALIONA
HA
DFIG
PAM
KC
Accipiter Capital Management's Q1 2018 Portfolio in Review
As of Q1 2018, Accipiter Capital Management held 4 positions worth $47.4M, down 3.7% from $49.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Accipiter Capital Management deployed $5.66M of net new capital in Q1 2018, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Cigna: 35,000 shares worth $5.87M.
By sector, the portfolio is most concentrated in Energy at 57% of assets, down from 68% a quarter earlier, followed by Healthcare.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $5.4M trimmed.
- Accipiter Capital Management's largest Q1 2018 buy was Cigna: 35,000 shares worth $5.87M.
- Accipiter Capital Management added most to Shire pic in Q1 2018, an estimated $4.13M increase.
- Accipiter Capital Management's biggest Q1 2018 reduction was Teva Pharmaceuticals, cutting an estimated $5.4M.
- Accipiter Capital Management's ten largest holdings make up 100% of its $47.4M portfolio in Q1 2018.
- Accipiter Capital Management opened 1 new position and closed 0 in Q1 2018.
- Accipiter Capital Management's portfolio value fell 3.7% quarter-over-quarter to $47.4M.
Based on Accipiter Capital Management's 13F filing for Q1 2018, filed 15 May 2018.